首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders
【24h】

Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders

机译:封闭胶体间隔缺损和专利植物卵巢的经截管关闭的最新发展

获取原文
获取原文并翻译 | 示例
           

摘要

Atrial septal defect (ASD) and patent foramen ovale (PFO) are common clinical congenital heart defects. As an effective method for the treatment of ASD and PFO, transcatheter closure with occluders presents many advantages, including safety, ease of operation, minimal invasiveness, and reduced complications. This contribution reviews the various types of occluders currently used in clinical applications and under development, including non degradable occluders, partially degradable occluders, and totally degradable occluders. A number of case studies are described in detail. Comparison is made on the treatment outcomes using different occulders. Future development of transcatheter closure is discussed, in particular the use of totally degradable occluders. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 433-443, 2018.
机译:心房隔膜缺陷(ASD)和专利诱饵卵巢(PFO)是常见的临床先天性心脏缺陷。 作为治疗ASD和PFO的有效方法,用封堵器的经截管闭合呈现许多优点,包括安全性,易于操作,侵袭性最小,并发症减少。 此贡献评估目前用于临床应用和开发中使用的各种类型的封闭者,包括不可降解的封闭者,部分可降解的封堵器,以及完全可降解的封闭者。 详细描述了许多案例研究。 使用不同的Overulders对治疗结果进行比较。 讨论了经转截管关闭的未来发展,特别是使用完全可降解的封堵器。 (c)2016 Wiley期刊,Inc.J生物保解率A型B:苹果生物摩特,106B:433-443,2018。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号